BLFS Historical PE Ratio Notes

— BioLife Solutions (ticker: BLFS) is a life sciences company specializing in biopreservation tools and services, with a focus on the storage, transport, and handling of biologic materials such as cells, tissues, and organs used in advanced therapies, including cell & gene therapies. The company's core products include biopreservation media, automated freezers, and cloud-connected storage solutions that are essential for pharmaceutical and biotech companies working on breakthrough treatments. When analyzing BLFS's historical PE ratio, it’s important to understand that fluctuations may reflect the volatility typical of emerging biotech supply companies: earnings can be highly variable due to reinvestment in R&D, acquisitions, and growth initiatives which sometimes depress short-term earnings even as revenue climbs. Moreover, market optimism about the future adoption of cell & gene therapies can push the PE ratio higher at times, as investors price in anticipated profits rather than current profitability. As you review historical charts for BLFS, consider that historically high PE ratios may not always indicate overvaluation, but rather the market's expectations for strong future earnings growth driven by the expanding cell & gene therapy market that BioLife Solutions supports.

On this page we presented the BLFS Historical PE Ratio information for BioLife Solns' stock. The average BLFS historical PE based on using the annualized quarterly earnings result at each measurement period (for the "E" in the PE calculation; and the closing price on earnings date as the "P") is 147.2. Meanwhile, using the trailing twelve month (TTM) quarterly earnings result as our method of calculation the "E" value at each measurement period, the average BLFS historical PE based on this TTM earnings result method is 198.8. Note: any PE calculations resulting in a value exceeding 500 were discarded as not meaningful. Note: any PE calculations involving negative earnings were discarded as not meaningful.

Let's now compare this BLFS historical PE result, against the recent PE: when this page was posted on 8/6/2026, the most recent closing price for BLFS had been 33.93, and the most recent quarterly earnings result, annualized, was 0.336. Meanwhile, the most recent TTM earnings summed to 0.204. From these numbers, we calculate the recent BLFS PE on 8/6/2026 based on annualized quarterly EPS was 101.0. Based on BLFS's history, that recent PE is low relative to the historical average, with the recent PE 31.4% lower than the historical average PE across our data set for BioLife Solns. Looking at the recent BLFS PE on 8/6/2026 based on TTM EPS, we calculate the ratio at 166.3. Based on BLFS's history, that recent PE is low relative to the historical average, with the recent PE 16.3% lower than the average PE across our BioLife Solns data set with TTM EPS used in the calculation at each period.

Another interesting BLFS historical PE Ratio calculation we look at is to take the median earnings per share of the last four quarters for BLFS, and then annualize the resulting value... with that annualized number then being used in the PE calculation. To walk through this math for BLFS, we start with the past four EPS numbers and we first sort them from lowest to highest: 0.04, 0.04, 0.04, and 0.08. We then toss out the highest and lowest result, and then take the average of those two middle numbers — 0.04 and 0.04 — which gives us the median of 0.04. Basically the way to think about this 0.04 number is this: for the trailing four earnings reports, 0.04 marks the "middle ground" number where BLFS has reported a value higher than 0.04 half the time, and has reported a value lower than 0.04 half the time. Annualizing that median value then gets us to 0.16/share, which we use as the denominator in our next PE calculation. With 33.93 as the numerator (as of 8/6/2026), the calculation is then 33.93 / 0.16 = 212.1 as the BLFS PE ratio as of 8/6/2026, based on that annualized median value we calculated.

For self directed investors doing their due diligence on BLFS or any other given stock, valuation analysis for BLFS can greatly benefit from studying the past earnings and resulting PE calculations. This exercise can help inform an analysis as to whether the past earnings trajectory and current versus historical PE ratios justify the current stock value.

That's why we bring you HistoricalPERatio.com to make it easy for investors to investigate BioLife Solns PE history or the past PE information for any stock in our coverage universe. And in your continued research we hope you will be sure to check out the further links included for earnings surprises history (beat/miss data) as well as next earnings dates for BLFS. Thanks for visiting, and the next time you need to research BLFS Historical PE Ratio or the ratio for another stock, we hope you'll think of our site, as your go-to historical PE ratio research resource of choice.